EFFECTIVENESS OF TNF INHIBITOR VERSUS ABATACEPT FOLLOWING TOCILIZUMAB FAILURE IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Akiyama, M. [1 ]
Kaneko, Y. [1 ]
Kondo, H. [1 ]
Takeuchi, T. [1 ]
机构：
[1] Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.1740
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0440
引用
收藏
页码：953 / 953
页数：1
相关论文
共 50 条
  • [1] COMPARISON BETWEEN TOCILIZUMAB AND ALTERNATVE TNF INHIBITOR AS A SECOND LINE FOLLOWING TNF INHIBITOR FAILURE IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Kunishita, Y.
    Yoshimi, R.
    Kishimoto, D.
    Kamiyama, R.
    Minegishi, K.
    Hama, M.
    Kirino, Y.
    Asami, Y.
    Yamazaki, T.
    Sekiguchi, A.
    Suda, A.
    Ideguchi, H.
    Ihata, A.
    Ohno, S.
    Ueda, A.
    Takeno, M.
    Kawai, T.
    Igarashi, T.
    Nagaoka, S.
    Ishigatsubo, Y.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 688 - 689
  • [2] Comparing the effectiveness and safety of Abatacept and Tocilizumab in elderly patients with rheumatoid arthritis
    Temmoku, Jumpei
    Miyata, Masayuki
    Suzuki, Eiji
    Sumichika, Yuya
    Saito, Kenji
    Yoshida, Shuhei
    Matsumoto, Haruki
    Fujita, Yuya
    Matsuoka, Naoki
    Asano, Tomoyuki
    Sato, Shuzo
    Watanabe, Hiroshi
    Migita, Kiyoshi
    [J]. PLOS ONE, 2022, 17 (09):
  • [3] Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry
    Harrold, Leslie R.
    Reed, George W.
    Solomon, Daniel H.
    Curtis, Jeffrey R.
    Liu, Mei
    Greenberg, Jeffrey D.
    Kremer, Joel M.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2016, 18
  • [4] Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry
    Leslie R. Harrold
    George W. Reed
    Daniel H. Solomon
    Jeffrey R. Curtis
    Mei Liu
    Jeffrey D. Greenberg
    Joel M. Kremer
    [J]. Arthritis Research & Therapy, 18
  • [5] OVERALL CANCER RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TNF INHIBITORS, TOCILIZUMAB, ABATACEPT, OR RITUXIMAB
    Wadstrom, H.
    Frisell, T.
    Askling, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 93 - 93
  • [6] CLINICAL EFFICACY OF TNF INHIBITORS AND ABATACEPT IN JAPANESE RHEUMATOID ARTHRITIS PATIENTS SWITCHING FROM TOCILIZUMAB
    Hirabara, S.
    Kojima, T.
    Takahashi, N.
    Yabe, Y.
    Kaneko, A.
    Kida, D.
    Hirano, Y.
    Ishiguro, N.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1057 - 1058
  • [7] COST-EFFECTIVENESS OF ABATACEPT FOR THE TREATMENT OF RHEUMATOID ARTHRITIS (RA) AFTER THE FAILURE OF A FIRST TNF INHIBITOR IN THE UNITED KINGDOM
    Pericleous, L.
    Lebmeier, M.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A307 - A308
  • [8] A COST-EFFECTIVENESS ANALYSIS OF ABATACEPT, TOCILIZUMAB, AND TNF-INHIBITOR COMPARED WITH RITUXIMAB AS A SECOND-LINE THERAPY FOR TREATMENT OF RHEUMATOID ARTHRITIS
    Huoponen, S.
    Aaltonen, K. J.
    Joensuu, J. T.
    Rutanen, J.
    Relas, H.
    Taimen, K.
    Puolakka, K.
    Sokka, T.
    Nordstrom, D.
    Blom, M.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A538 - A538
  • [9] Comparative effectiveness of abatacept versus TNF inhibitors in rheumatoid arthritis patients who are ACPA and shared epitope positive
    Harrold, Leslie R.
    Wittstock, Keith
    Kelly, Sheila
    Han, Xue
    Zhuo, Joe
    Schrader, Amy
    Middaugh, Nicole
    Moore, Page C.
    Khaychuk, Vadim
    [J]. ADVANCES IN RHEUMATOLOGY, 2024, 64 (01)
  • [10] Comparative effectiveness of abatacept versus TNF inhibitors in rheumatoid arthritis patients who are ACPA and shared epitope positive
    Leslie R. Harrold
    Keith Wittstock
    Sheila Kelly
    Xue Han
    Joe Zhuo
    Amy Schrader
    Nicole Middaugh
    Page C. Moore
    Vadim Khaychuk
    [J]. Advances in Rheumatology, 64
12345